drugset / Trial / NCT03009799

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)

NCT03009799

RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical investigation aims at demonstrating that NCX-4240 is effective and safe in decreasing the number of days where adenoviral conjunctivis is detected in the eye and in reducing the duration and/or the severity of the signs and symptoms of adenoviral conjunctivis

Timeline

Start
2017-01
Primary completion
2017-08
Completion
2017-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Iota-Carrageenan Other / unclassified 3.2 mg/ml Other

Indications